obesity treatment management platform
Scope
Date
~
-
Bio & Pharma
Bridge Biotherapeutics, Pinotbio develop lung cancer treatment
South Korea's biotech companies Bridge Biotherapeutics Inc. and Pinotbio on Thursday said they will jointly develop new antibody-drug conjugates (AD...
Jan 27, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N to introduce biosimilars for bone disease treatment from Spain
South Korea's biohealth company HK inno.N said on Wednesday that it has signed an agreement with Spanish pharmaceutical company mAbxience SA to intr...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Hancom Carelink invests in bio big data venture 3bigs
South Korea's Hancom Carelink, a digital health care company under Hancom Group, on Wednesday said it bought an unspecified stake in the bio big dat...
Jan 26, 2023 (Gmt+09:00)
-
Chief Executives
Samsung Biologics CEO focuses on global business
John Rim, chief executive of Samsung BioLogics will directly lead his company's global sales operations for biopharmaceuticals through contract deve...
Jan 26, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung earns ISO 22301 certification for business continuity
Samsung Electronics Co.'s device solutions division has achieved ISO 22301 certification, the international business continuity management system (B...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
Inventage Lab launches clinical trials for addiction treatment in Australia
South Korea's Inventage Lab, a developer of a drug delivery system platform, on Wednesday said it received approval from the Human Research Ethics C...
Jan 26, 2023 (Gmt+09:00)
-
Bio & Pharma
ST Pharm exports $14.6 mn worth of drug ingredients to Europe
ST Pharm Co., a South Korean company specializing in contract development and manufacturing of drug ingredients, has signed a supply contract worth ...
Jan 20, 2023 (Gmt+09:00)
-
Bio & Pharma
LG Chem completes acquisition of US biotech firm AVEO
LG Chem Ltd. is set to complete its $571 million purchase of the US biotech firm AVEO Pharmaceuticals Inc. on Friday, which would strengthen its ant...
Jan 19, 2023 (Gmt+09:00)
-
Asset management
Mirae Asset sees 100-fold jump in deposits 15 years after entering India
South Korea's Mirae Asset Global Investments on Wednesday marked the 15th anniversary of its incorporated company in India that now has 21 trillion ...
Jan 19, 2023 (Gmt+09:00)
-
Automobiles
Epikar inks MOU with Singapore's NTU Research Center
South Korea's auto distribution digital solutions company Epikar said on Wednesday that it has signed a memorandum of understanding (MOU) for R&...
Jan 19, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma's Sanfilippo treatment eligible for FDA priority review
GC Biopharma Corp. said on Wednesday that its Sanfilippo type A treatment, which is under joint development with Novel Pharma, a bio-venture special...
Jan 18, 2023 (Gmt+09:00)
-
Bio & Pharma
MedPacto's anti-cancer substance designated as US FDA fast-track item
South Korean biotech company MedPacto Inc. ’s Vactosertib monotherapy for osteosarcoma patients has been designated as a fast-track developmen...
Jan 18, 2023 (Gmt+09:00)
-
Travel & Leisure
Modetour signs agreement with mobility platform Danida
South Korea's travel agency network Modetour Network Inc. said Tuesday that it signed a memorandum of understanding (MOU) with mobility platform Dan...
Jan 18, 2023 (Gmt+09:00)
-
Korean startups
Medical platform operator Integration raises $8 mn in Series B funding
Integration Inc., which operates specialized platforms for medical personnel such as Traditional Korean Medicine doctors and dentists, has raised 10...
Jan 17, 2023 (Gmt+09:00)
-
Banking & Finance
Kookmin Bank launches foreign currency trading platform KB Star FX
South Korea's largest lender Kookmin Bank on Monday launched its new contactless platform for foreign exchange transactions dubbed KB Star FX.The on...
Jan 17, 2023 (Gmt+09:00)
-
Cloud computing
Bespin Global establishes Vietnam Tech Center for cloud, digital innovation
South Korea's cloud management company Bespin Global will foster cloud and digital innovation industries in Central Vietnam. To this end, the compan...
Jan 17, 2023 (Gmt+09:00)
-
North Korea
South Korea Revives Nuclear Debate as Tensions With the North Rise
SEOUL—Rising tensions on the Korean Peninsula and Pyongyang’s spree of weapons tests are fueling a debate in South Korea over the deploy...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for EMA approval of smaller dose formulation of Yuflyma
Celltrion Inc. announced on Monday it applied to the European Medicines Agency (EMA) for approval of a 20 mg/0.2 mL formulation of Yuflyma, a biosim...
Jan 16, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Chemicals launches uremia itching treatment tablet
SK Chemicals said on Monday that it has launched Remitch in orally disintegrating tablets, a treatment for intractable uremic pruritus (uremia itchi...
Jan 16, 2023 (Gmt+09:00)
-
Food & Beverage
Pulmuone builds data sharing cluster for factories
South Korea's major plant-based food company Pulmuone Co. Ltd. said on Monday that it has built a "digital cluster smart factory" that can share, in...
Jan 16, 2023 (Gmt+09:00)
-
IPOs
Korean grocery delivery platform Oasis set for February IPO
South Korean grocery delivery platform Oasis Corp. aims to raise up to $166 million through a listing next month, becoming the country’s first...
Jan 13, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Orchestra PE acquires KFC Korea for about $50 mn
Asia-focused Orchestra Private Equity agreed on Wednesday to buy a 100% stake in the South Korean operations of fast food chain KFC for around 60 bi...
Jan 12, 2023 (Gmt+09:00)
-
Bio & Pharma
HK inno.N gets approval to sell K-CAB in Singapore
South Korean biohealth company HK inno.N said on Wednesday that it has received an item approval for K-CAB, a new drug for gastroesophageal reflux d...
Jan 12, 2023 (Gmt+09:00)
-
ESG
3 HD Hyundai affiliates to help ESG management of biz partners
Three construction machinery affiliates of South Korea's HD Hyundai will support environmental, social and governance (ESG) management of their part...
Jan 12, 2023 (Gmt+09:00)
-
Bio & Pharma
Prestige Biopharma attains patent for solid cancer treatment antibody
Prestige Biopharma Korea said on Tuesday that it has obtained a domestic patent for the CTHRC1 neutralizing antibody of the drug candidate PBP1710. ...
Jan 12, 2023 (Gmt+09:00)
-
Shareholder activism
Anda pushes for right to copy KT&G shareholder list
South Korea's Anda Asset Management Co. said on Tuesday it applied for an injunction Jan. 9 to view and copy the shareholders’ list of KT&...
Jan 10, 2023 (Gmt+09:00)
-
Mergers & Acquisitions
Korean activist fund KCGI buys Meritz Asset Management
A consortium led by Korea Corporate Governance Improvement Fund (KCGI), a local activist fund, said on Jan. 9 it signed a share purchase agreement l...
Jan 09, 2023 (Gmt+09:00)
-
Bio & Pharma
Kolon signs MOU with Hanyang Univ. to develop gene therapy treatments
Kolon Industries Inc.'s Future Technology Institute said on Thursday that it had signed a memorandum of understanding with the Hanyang University In...
Jan 05, 2023 (Gmt+09:00)
-
Bio & Pharma
Daewoong, Onchorus to undertake research on mRNA anticancer drugs
Daewoong Pharmaceutical said on Thursday that it has signed a joint R&D and commercialization agreement with America's biopharmaceutical venture...
Jan 05, 2023 (Gmt+09:00)
-
ESG
SK Shieldus acquires environmental management standard certification
South Korea's cybersecurity service provider SK Shieldus said on Wednesday that it had obtained ISO 14001, an international standard for environment...
Jan 04, 2023 (Gmt+09:00)